Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Bipolar Disorder
Interventions
DRUG

Licarbazepine

DRUG

Placebo

Trial Locations (44)

10305

Investigational Site, Staten Island

37115

Investigational Site, Madison

48334

Investigational Site, Farmington Hills

53227

Investigational Site, West Allis

66160

Investigational Site, Kansas City

71101

Investigational Site, Shreveport

75235

Investigational Site, Dallas

77401

Investigational Site, Bellaire

90623

Investigational Site, La Palma

98004

Investigational Site, Bellevue

98033

Investigational Site, Kirkland

02143

Investigational Site, Somerville

Unknown

Novartis Investigational Site, Vienna

Novartis investigator site, Greater Sudbury

Novartis Investigational Site, Kelowna

Novartis investigator site, London

Novartis investigator site, Montreal

Novartis investigator site, Vancouver

Novartis investigator site, Verdun

Guatemala, Bogotá

Guatemala, Medellín

Guatemala, Pareira

Novartis Investigational Site, Brno

Novartis Investigational Site, Hradec Králové

Novartis Investigational Site, Prague

Novartis Investigational Site, Berlin

Novartis Investigational Site, Bochum

Novartis Investigational Site, Dresden

Novartis Investigational Site, Ingolstadt

Novartis Investigational Site, Mannheim

Novartis Investigational Site, Würzburg

Novartis Investigational Site, Guatemala City

Novartis Investigational Site, Lima

Novartis Investigational Site, Moscow

Novartis Investigational Site, Yaroslavl

Novartis Investigational Site, Bojnice

Novartis Investigational Site, Michalovce

Novartis Investigational Site, Durban

Novartis Investigational Site, Dnipro

Novartis Investigational Site, Kiev

Novartis Investigational Site, Luhansk

Novartis Investigational Site, Odesa

Novartis Investigational Site, Simferopol

Novartis Investigational Site, Caracas

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY